Weight Loss During Topiramate Treatment in a Severely Obese Adolescent with Congenital Adrenal Hyperplasia and Migraine
Youth with classical congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency exhibit an increased prevalence of obesity, early adiposity rebound, and increased abdominal adiposity compared to unaffected youth. Current obesity management in CAH largely focuses on lifestyle modifications...
Saved in:
Main Authors: | Amy Seagroves (Author), Heather M. Ross (Author), Alaina P. Vidmar (Author), Mitchell E. Geffner (Author), William S. Kim (Author), Darryl Hwang (Author), Claudia Borzutzky (Author), Nicole R. Fraga (Author), Mimi S. Kim (Author) |
---|---|
Format: | Book |
Published: |
Galenos Yayincilik,
2023-03-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topiramate in Pediatric Migraine
by: J Gordon Millichap
Published: (2009) -
Differences in Hyperandrogenism Related to Early Detection of Non-Classical Congenital Adrenal Hyperplasia on Second Newborn Screen
by: Bonnie McCann-Crosby, et al.
Published: (2023) -
Topiramate and Cognitive Function in Migraine
by: J Gordon Millichap
Published: (2010) -
A Case of Prenatally Diagnosed Congenital Adrenal Hyperplasia With Brain Morphometric Differences
by: Vidya Rajagopalan PhD, et al.
Published: (2022) -
Topiramate-Induced Cough in Migraine Prophylaxis
by: J Gordon Millichap
Published: (2009)